scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1029579407 |
P356 | DOI | 10.1186/S40064-015-1653-8 |
P932 | PMC publication ID | 4700031 |
P698 | PubMed publication ID | 26759747 |
P5875 | ResearchGate publication ID | 290431823 |
P2093 | author name string | Hazem Elewa | |
Osama Abdelsamad | |||
Amr Mohamed Fahmi | |||
P2860 | cites work | Interaction of rifampin and warfarin | Q66918873 |
Complex interaction of rifampin and warfarin | Q67942877 | ||
Proposal for a new tool to evaluate drug interaction cases | Q80050597 | ||
Elevated international normalized ratio values associated with concomitant use of warfarin and ceftriaxone | Q84800303 | ||
Impact of drug interactions when medications are stopped: the often forgotten risks | Q87613725 | ||
Cytochrome P4502C9: an enzyme of major importance in human drug metabolism | Q24683497 | ||
Diagnosis, treatment, and long-term management of Kawasaki disease | Q28171298 | ||
Warfarin therapy: evolving strategies in anticoagulation. | Q33535795 | ||
Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q34252907 | ||
Warfarin and its interactions with foods, herbs and other dietary supplements | Q34566453 | ||
Rifampicin-warfarin interaction leading to macroscopic hematuria: a case report and review of the literature. | Q34704814 | ||
Update on rifampin and rifabutin drug interactions | Q34750386 | ||
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q35752573 | ||
Update on the interaction of rifampin and warfarin | Q36836574 | ||
Describing the profile of patients on concurrent rifampin and warfarin therapy in western Kenya: a case series | Q37199759 | ||
Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy | Q37956597 | ||
Human P450 metabolism of warfarin | Q41334623 | ||
A review of enzyme induction of warfarin metabolism with recommendations for patient management | Q41607931 | ||
Update on rifampin drug interactions, III. | Q41653191 | ||
Rifampin and Warfarin: A Drug Interaction | Q41910294 | ||
Inability to achieve a therapeutic INR value while on concurrent warfarin and rifampin | Q43199883 | ||
Difficulties in anticoagulation management during coadministration of warfarin and rifampin | Q43767201 | ||
General framework for the prediction of oral drug interactions caused by CYP3A4 induction from in vivo information | Q45041991 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | rifampicin | Q422652 |
infective endocarditis | Q2450598 | ||
P304 | page(s) | 8 | |
P577 | publication date | 2016-01-04 | |
P1433 | published in | SpringerPlus | Q24055190 |
P1476 | title | Rifampin-warfarin interaction in a mitral valve replacement patient receiving rifampin for infective endocarditis: a case report | |
P478 | volume | 5 |